Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DCVax-L |
Trade Name | |
Synonyms | DCVax-Lung |
Drug Descriptions |
DCVax-L is a lung cancer vaccine composed of patient-derived dendritic cells that have been transduced with a patient tumor-specific antigen, potentially resulting in increased anti-tumor immunity (PMID: 29843811). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C26446 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DCVax-L | DCVax-L | 0 | 2 |
DCVax-L + Nivolumab | DCVax-L Nivolumab | 0 | 1 |